Drug Pipeline

Arsenic Trioxide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
2
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07503730 Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid… APL Recruiting
NCT02339740 Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic… Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA Active, Not Recruiting
Phase 2
NCT01409161 Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients… Acute Promyelocytic Leukemia With PML-RARA Recruiting
Phase 1
NCT07348107 ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With… Advanced Pancreatic Ductal Adenocarcinoma Not Yet Recruiting
Sponsors Running Arsenic Trioxide Trials
M.D. Anderson Cancer Center (1) Children's Oncology Group (1) Daniel Breadner (1) First Affiliated Hospital Xi'an Jiaotong University (1)
Disease Areas
Leukemia (2) Pancreatic Cancer (1)
Get alerts when Arsenic Trioxide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free